GAFNAM Capitalization-Weighted

The chart shows the growth of an initial investment of $10,000 in GAFNAM Capitalization-Weighted, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

As of Jun 12, 2026, the GAFNAM Capitalization-Weighted returned -0.50% Year-To-Date and 32.75% of annualized return in the last 10 years.

Based on dividend-adjusted daily data since May 18, 2012, GAFNAM Capitalization-Weighted's average daily return is +0.12%, while the average monthly return is +2.43%. At this rate, an investment would double in approximately 2.4 years.

Historically, 66% of months were positive and 34% were negative. The best month was Apr 2020 with a return of +16.8%, while the worst month was Apr 2022 at -16.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.

On a daily basis, GAFNAM Capitalization-Weighted closed higher 56% of trading days. The best single day was Apr 9, 2025 with a return of +13.1%, while the worst single day was Mar 16, 2020 at -13.1%.

GAFNAM Capitalization-Weighted has an annualized alpha of 13.46%, beta of 1.25, and R2 of 0.73 versus S&P 500 Index. Calculated based on daily prices since May 18, 2012.

• This portfolio captured 171.36% of S&P 500 Index gains but only 96.98% of its losses - a favorable profile for investors.
• This portfolio generated an annualized alpha of 13.46% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.

GAFNAM Capitalization-Weighted has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

GAFNAM Capitalization-Weighted ranks 22 for risk / return — below 22% of Portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

The current GAFNAM Capitalization-Weighted Sharpe ratio is 1.34 as of Jun 12, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.50 to 2.36, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of GAFNAM Capitalization-Weighted compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

GAFNAM Capitalization-Weighted provided a 0.40% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the GAFNAM Capitalization-Weighted. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the GAFNAM Capitalization-Weighted was 43.17%, occurring on Nov 3, 2022. Recovery took 151 trading sessions.

The current GAFNAM Capitalization-Weighted drawdown is 8.19%.

The chart below shows the rolling one-month volatility.